Xiaowan Han

473 total citations
33 papers, 346 citations indexed

About

Xiaowan Han is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Xiaowan Han has authored 33 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Oncology. Recurrent topics in Xiaowan Han's work include Peroxisome Proliferator-Activated Receptors (4 papers), Extracellular vesicles in disease (4 papers) and Luminescence and Fluorescent Materials (4 papers). Xiaowan Han is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (4 papers), Extracellular vesicles in disease (4 papers) and Luminescence and Fluorescent Materials (4 papers). Xiaowan Han collaborates with scholars based in China, United States and Germany. Xiaowan Han's co-authors include Yanni Xu, Shuyi Si, Ni Li, Yongzhen Li, Hai‐Yu Hu, Tingting Feng, Ningyu Zhu, Qingyang Zhang, Jinque Luo and Minghua Chen and has published in prestigious journals such as Analytical Chemistry, Scientific Reports and The FASEB Journal.

In The Last Decade

Xiaowan Han

30 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaowan Han China 12 179 50 45 41 39 33 346
Han Jin China 11 173 1.0× 20 0.4× 55 1.2× 24 0.6× 31 0.8× 37 408
Haixia Zhang China 10 169 0.9× 52 1.0× 11 0.2× 32 0.8× 38 1.0× 33 397
Tianyi Ma China 9 159 0.9× 79 1.6× 13 0.3× 26 0.6× 39 1.0× 28 331
Subrahmanya S. Ganti India 8 205 1.1× 38 0.8× 16 0.4× 32 0.8× 22 0.6× 15 384
Chia‐Yao Shen Taiwan 12 218 1.2× 66 1.3× 12 0.3× 44 1.1× 47 1.2× 18 412
Huizhi Fan China 10 287 1.6× 33 0.7× 41 0.9× 20 0.5× 27 0.7× 27 506
Koji Ochiai Japan 16 183 1.0× 21 0.4× 45 1.0× 91 2.2× 27 0.7× 38 554
Rishabh Dev India 12 94 0.5× 27 0.5× 23 0.5× 53 1.3× 38 1.0× 39 380
Jianjie Wang China 10 140 0.8× 30 0.6× 16 0.4× 23 0.6× 84 2.2× 20 370

Countries citing papers authored by Xiaowan Han

Since Specialization
Citations

This map shows the geographic impact of Xiaowan Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowan Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowan Han more than expected).

Fields of papers citing papers by Xiaowan Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowan Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowan Han. The network helps show where Xiaowan Han may publish in the future.

Co-authorship network of co-authors of Xiaowan Han

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowan Han. A scholar is included among the top collaborators of Xiaowan Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowan Han. Xiaowan Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qian, et al.. (2025). An Activatable Long‐Fluorescence‐Lifetime Probe for Exploring the Dual Function of StrH in Biofilm Formation and Necroptosis. Advanced Healthcare Materials. 14(9). e2404252–e2404252. 1 indexed citations
2.
Ji, Xiang, et al.. (2025). Cardiovascular System is Influenced by Skeletal Muscle-derived Extracellular Vesicles, Myokines and MicroRNAs Based on Interorgan Communication: A Systematic Review. International Journal of Medical Sciences. 22(10). 2382–2397. 1 indexed citations
3.
Zhang, Yuyan, Xinwei Wei, Ren Sheng, et al.. (2025). A Novel RANKL/RANK Inhibitor IMB-R38 Inhibits Osteoporosis Through Regulating Bone Metabolism. International Journal of Molecular Sciences. 26(24). 12151–12151.
4.
5.
Han, Xiaowan, et al.. (2025). Non-targeted metabolomic analysis of Xueshuantong injection in patients with STEMI. Fitoterapia. 186. 106802–106802.
6.
Li, Shunwang, Jinque Luo, Huan Liu, et al.. (2024). ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet–Fed ApoE −/− Mice by Regulating Lipoprotein Metabolism and Promoting Cholesterol Efflux. Arteriosclerosis Thrombosis and Vascular Biology. 44(12). 2428–2449. 9 indexed citations
7.
Sheng, Ren, Yining Li, Chang Liu, et al.. (2024). A pan-PPAR agonist E17241 ameliorates hyperglycemia and diabetic dyslipidemia in KKAy mice via up-regulating ABCA1 in islet, liver, and white adipose tissue. Biomedicine & Pharmacotherapy. 172. 116220–116220. 7 indexed citations
8.
Li, Tong, et al.. (2023). The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy. Frontiers in Cardiovascular Medicine. 10. 1291450–1291450. 8 indexed citations
9.
10.
Li, Tong, Xiaowan Han, Shiqi Chen, et al.. (2022). Effects of Exercise on Extracellular Vesicles in Patients with Metabolic Dysfunction: a Systematic Review. Journal of Cardiovascular Translational Research. 16(1). 97–111. 6 indexed citations
11.
Liu, Qian, Miao Yang, Xiaowan Han, et al.. (2022). Donor manipulation for constructing a pH sensing thermally activated delayed fluorescent probe to detect alkaliphiles. Talanta. 246. 123493–123493. 12 indexed citations
12.
Li, Tong, Hao Ding, Shiqi Chen, et al.. (2022). Effect of Extracellular Vesicles From Multiple Cells on Vascular Smooth Muscle Cells in Atherosclerosis. Frontiers in Pharmacology. 13. 857331–857331. 11 indexed citations
13.
Li, Ni, Xiaowan Han, Jing Zhang, et al.. (2022). LXR agonist inhibits inflammation through regulating MyD88 mRNA alternative splicing. Frontiers in Pharmacology. 13. 973612–973612. 13 indexed citations
14.
Liu, Chao, Yining Li, Ren Sheng, et al.. (2021). Synthesis of N-methylpyridine-chlorofuranformamide analogs as novel OPG up-regulators and inhibitors of RANKL-induced osteoclastogenesis. Bioorganic Chemistry. 116. 105361–105361. 2 indexed citations
15.
Han, Xiaowan, Yang Li, H. J. Yang, et al.. (2021). Exercise and Circulating Microparticles in Healthy Subjects. Journal of Cardiovascular Translational Research. 14(5). 841–856. 7 indexed citations
16.
Li, Yining, Weizhi Wang, Xiaowan Han, et al.. (2020). Nuclear Factor Erythroid 2 Related Factor 2 Activator JC-5411 Inhibits Atherosclerosis Through Suppression of Inflammation and Regulation of Lipid Metabolism. Frontiers in Pharmacology. 11. 532568–532568. 15 indexed citations
17.
Zuo, Xuan, et al.. (2019). The anti-atherosclerotic effect and mechanism study of berberine in hyperlipidemic ApoE-/- mice.. Yaoxue xuebao. 54(1). 104–110. 1 indexed citations
18.
Han, Xiaowan, Shiqiang Gong, Li Ni, et al.. (2019). A Novel Small Molecule Which Increases Osteoprotegerin Expression and Protects Against Ovariectomy-Related Bone Loss in Rats. Frontiers in Pharmacology. 10. 103–103. 9 indexed citations
19.
Feng, Tingting, Peng Liu, Jinque Luo, et al.. (2018). SIRT1 activator E1231 protects from experimental atherosclerosis and lowers plasma cholesterol and triglycerides by enhancing ABCA1 expression. Atherosclerosis. 274. 172–181. 25 indexed citations
20.
Liu, Chang, Tingting Feng, Ningyu Zhu, et al.. (2015). Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis. Scientific Reports. 5(1). 12185–12185. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Han Jin Breakdown of academic impact, for papers by Haixia Zhang Breakdown of academic impact, for papers by Tianyi Ma Breakdown of academic impact, for papers by Subrahmanya S. Ganti Breakdown of academic impact, for papers by Chia‐Yao Shen Breakdown of academic impact, for papers by Huizhi Fan Breakdown of academic impact, for papers by Koji Ochiai Breakdown of academic impact, for papers by Rishabh Dev Breakdown of academic impact, for papers by Jianjie Wang
Rankless by CCL
2026